Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Parallel, Multicenter Randomized Controlled Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis

NCT04642326 is registered in ClinicalTrials.gov with RD Global Araştirma Geliştirme Sağlik Ilaç Inşaat Yatirimlari A.Ş. as lead sponsor.

NCT NCT04642326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Parallel, Multicenter Randomized Controlled Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis
Lead sponsor
RD Global Araştirma Geliştirme Sağlik Ilaç Inşaat Yatirimlari A.Ş.
Phase
Not applicable
Overall status
Unknown status
Start date
June 26, 2020
Completion date
May 4, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19